The results point to the ability of Homspera to enhance formation of early-stage blood cells from adult hematopoietic (blood-forming) stem cells. The studies, performed by University of Medicine and Dentistry of New Jersey (UMDNJ) not only were consistent with previous stem cell study results, but also demonstrated the potency of Homspera.
The study compared Homspera to Substance P, a peptide found naturally in the body, which is a known stimulant of hematopoiesis. The data indicated Homspera was more effective than Substance P at stimulating hematopoiesis. This impact on the production of blood cells suggests the possibility that Homspera may have clinical application in strengthening the human immune system.
The UMDNJ confirmatory study demonstrated Homspera significantly enhanced stem cell differentiation. More than doubling (130%) the differentiation exhibited in control cultures, Homspera’s activity was most prominent in the production of two types of white blood cells-granulocytes and macrophages. In comparison, Substance P increased activity over control cultures by only 50%, and required dosing at a much higher concentration than did Homspera.